BIOLARGO, INC. (ticker: BLGO) is an OTC-listed chemicals company. DredgeCap's structured extraction of BLGO's SEC filings surfaces 19 active risk signals, including 18 late-filing signals, and 1 auditor-change signal. BLGO reported $12.23M in revenue and -$3.80M for the period ending 2023-12-31, with operating cash flow of -$8.30M. Cash and equivalents stood at $3.88M (up 9.4% year-over-year). Total assets of $8.31M exceed total liabilities of $6.79M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
BLGO Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for BIOLARGO, INC. (BLGO) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.